PAX5 and acute lymphoblastic leukemia: To date six independent studies have included exome sequencing and/or insertional mutagenesis of mouse B ALL samples generated by mutation of Pax5. The convergence of findings of these studies demonstrates the value of multimodal screening in mice to validate mutation profiles of human tumors.